36 results
CORRESP
CGTX
Cognition Therapeutics Inc
29 Jul 21
Correspondence with SEC
12:00am
”), weighted at 5.0% probability, (ii) initial public offering – long term (the “IPO (Long Term) Scenario”), weighted at 5.0% probability, (iii) an option … assumes a short term IPO scenario prior to the completion of the Company’s Phase 2 trials and the IPO (Long Term) Scenario assumes a longer term IPO
DEF 14A
CGTX
Cognition Therapeutics Inc
25 Apr 22
Definitive proxy
5:28pm
and management team. We view Environmental, Social and Governance, or ESG, initiatives as long-term value drivers for us and our stockholders. Our focus … structure is appropriate to effectively address the specific needs of our business and the long-term interests of our stockholders.
BOARD COMMITTEES
8-K
EX-10.1
2hh9o
1 May 23
Departure of Directors or Certain Officers
7:30am
DRS
EX-10.6
q6buh5h
7 May 21
Draft registration statement
12:00am
8-K
EX-1.1
qxvndf
13 Mar 24
Entry into a Material Definitive Agreement
4:07pm
S-1
EX-10.7
je9ayn8 gci
19 Jul 21
IPO registration
7:02am
8-K
EX-10.1
cynbysu00v5apolzh7g4
23 Dec 22
Entry into a Material Definitive Agreement
4:24pm
8-K
EX-1.1
c4iykgj lwk
14 Nov 22
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
8:00am
S-3
EX-1.2
pfqp9
23 Dec 22
Shelf registration
4:16pm
DRS
EX-10.7
n9su k8juad8ko4e
7 May 21
Draft registration statement
12:00am
S-1
EX-10.8
j5qmh lki2c9qie8haf
19 Jul 21
IPO registration
7:02am
DRS
EX-10.14
3cg10hw
7 May 21
Draft registration statement
12:00am
S-1
EX-10.15
u3a1p8e7fb86
19 Jul 21
IPO registration
7:02am
424B5
j9x aenlz
11 Mar 24
Prospectus supplement for primary offering
4:06pm
424B5
hjxpym7p3ml
13 Mar 24
Prospectus supplement for primary offering
4:04pm